<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Graft failure (GF) remains a major problem in cord blood transplantation (CBT) </plain></SENT>
<SENT sid="1" pm="."><plain>In 36 adult patients undergoing CBT at our hospital between July 2003 and December 2009, six patients developed GF (primary, n = 5; secondary, n = 1) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> six patients underwent second stem cell transplantation (SCT) </plain></SENT>
<SENT sid="3" pm="."><plain>Three patients had <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, one had <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, one had <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and one had <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Five patients were complicated with <z:hpo ids='HP_0100806'>sepsis</z:hpo> before the second SCT </plain></SENT>
<SENT sid="5" pm="."><plain>The median elapsed time from first CBT to the diagnosis of primary GF was 27 days </plain></SENT>
<SENT sid="6" pm="."><plain>Secondary GF was diagnosed on day 567 </plain></SENT>
<SENT sid="7" pm="."><plain>The median elapsed time from primary GF to second SCT was 9 days </plain></SENT>
<SENT sid="8" pm="."><plain>In the patient with secondary GF, the elapsed time was 35 days </plain></SENT>
<SENT sid="9" pm="."><plain>Cord blood grafts were used in 5 patients and a matched sibling donor in one patient </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 6 patients underwent second transplantation following a modified '1-day'-based preparative regimen consisting of fludarabine (30 mg/m(2), 1 day, n = 2; 2 days, n = 1; 3 days, n = 3), <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (2 g/m(2)), and total body irradiation (2 Gy) </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients achieved neutrophil engraftment, and the median elapsed time from second SCT to engraftment was 35 days </plain></SENT>
<SENT sid="12" pm="."><plain>Four patients remain alive between 5 and 38 months after second SCT. '1-day'-based short-term conditioning may be a promising salvage regimen </plain></SENT>
</text></document>